Calendar

Aug
23
Fri
2019
Canary CREST Program Ends: Ice Cream Social
Canary CREST Program Ends: Ice Cream Social
Aug 23 @ 2:00 pm – 3:00 pm
Oct
23
Wed
2019
Cancer Early Detection Seminar Series - Michael Shen, Ph.D.
Cancer Early Detection Seminar Series – Michael Shen, Ph.D.
Cancer Early Detection Seminar Series - Michael Shen, Ph.D.

Cancer Early Detection Seminar

“Best Practices in Hip Imaging”

Michael Shen, PhD
Professor of Medicine, Genetics and Development, Urology and Systems Biology
Columbia University Medical Center

ABSTRACT
TBD

_____________________________________________
Hosted by
Sanjiv Sam Gambhir, MD, PhD<https://med.stanford.edu/profiles/sanjiv-gambhir>

Sponsored by
The Canary Center and the Stanford Cancer Institute
Stanford University

If you would like to be included on the email distribution list for weekly reminders, contact Ashley Williams (ashleylw.at.stanford.edu)

RSVP and more info at: https://www.onlineregistrationcenter.com/register/222/page1.asp?m=298&c=41

Dec
11
Wed
2019
AIMI, IBIIS & RSL Special Seminar - John Stafford & Bjorn Carey @ Clark Center - S360
AIMI, IBIIS & RSL Special Seminar – John Stafford & Bjorn Carey
Dec 11 @ 10:00 am – 11:00 am Clark Center - S360
AIMI, IBIIS & RSL Special Seminar - John Stafford & Bjorn Carey @ Clark Center - S360

“Messaging in the Age of Microtargeting”

John Stafford
Assistant Vice President
Digital Strategy
Stanford University

Bjorn Carey
Senior Director
Digital Strategy
Stanford University

Join via Zoom: https://stanford.zoom.us/j/400566542

Abstract:
Communications has become increasingly data-driven, targeted, and personalized. This has changed how Stanford analyzes communications opportunities from a research perspective and how it engages with relevant audiences. In this presentation, John and Bjorn will share the data and communications strategy underlying three communications initiatives and the resulting execution. They will also provide practical advice for individual thought leadership and communications in this dynamic environment.

About:
John Stafford, MA ’06, is currently Assistant Vice President for Digital Strategy at Stanford, the most senior digital communications role in the university. John is responsible for all aspects of creating a world-class digital communications function: setting the group’s strategy, building analytics and insight programs, counseling on crisis communications, leading multi-channel messaging initiatives, and advising colleagues across the University. He received a Master’s Degree in Communication from Stanford, a B.A. in History from the University of San Francisco, and was a founding advisor to Stanford Medicine X.

Refreshments will be provided.

Jan
23
Thu
2020
Early Detection Seminar Series - Victoria Seewaldt, M.D. @ Beckman Center, Munzer Auditorium (B060)
Early Detection Seminar Series – Victoria Seewaldt, M.D.
Jan 23 @ 11:00 am – 12:00 pm Beckman Center, Munzer Auditorium (B060)
Early Detection Seminar Series - Victoria Seewaldt, M.D. @ Beckman Center, Munzer Auditorium (B060)

CEDSS: “Strategies to Identify Aggressive Breast Cancer Biology in Black and Latina Women”

Victoria Seewaldt, MD
Ruth Ziegler Professor and Chair, Department of Population Sciences
Associate Director for Population Sciences Research, Comprehensive Cancer Center
City of Hope

Beckman Center, Munzer Auditorium (B060)
11:00am – 12:00pm Seminar & Discussion
12:00pm – 12:15pm Reception & Light Refreshments
RSVP here: https://www.onlineregistrationcenter.com/VictoriaSeewaldt

ABSTRACT

Over 90% of breast cancer is cured; yet there remain highly aggressive breast cancers that develop rapidly and are extremely difficult to treat, much less prevent. Examples are triple-negative breast cancer in Black/African American women and luminal B breast cancers in Black/African Americans and Latinas. Breast cancers that rapidly develop between breast imaging are called “interval cancers”. Here we aim to investigate biologically aggressive precancerous breast lesions and their matched invasive breast cancers in women of diverse race and ethnicity. Our team has the unique ability to perform single cell in situ transcriptional profiling in combination with dynamic and spatial genomics/proteomics; this allows us to identify multi-dimensional spatial and temporal relationships that drive the transition from biologically aggressive pre-cancer to interval breast cancer.

 

ABOUT

Victoria Seewaldt, M.D., is an accomplished clinician and researcher who’s devoted to improving the lives of her patients and the community at large. She has led community outreach education efforts on cancer prevention through personal wellbeing and directed research aimed at finding biomarkers that can be used for early cancer detection, particularly triple-negative breast cancers that are especially resistant to treatment.

At City of Hope, Dr. Seewaldt will direct efforts to provide breast cancer education, free breast cancer screening and treatment, mentorship of young minority scholars, and a forum for community partnered trials. Clinically, Dr. Seewaldt aims to empower women at high breast cancer risk to be full partners in developing wellness strategies to promote personal health.

Dr. Seewaldt received her medical degree from the University of California, Davis, and completed her residency and clinical fellowship at the University of Washington in Seattle. She then pursued a medical oncology fellowship with the Fred Hutchinson Cancer Research Center and then became an assistant professor at Ohio State University. Afterwards, she transferred to Duke University, where she held various clinical, academic and leadership roles in its School of Medicine and Comprehensive Cancer Center — most recently as a professor, co-leader of the breast and ovarian cancer program and head of the cancer breast prevention program — before joining City of Hope.

Mar
19
Thu
2020
CANCELLED - Cancer Early Detection Seminar Series - Azra Raza, M.D. @ CANCELLED
CANCELLED – Cancer Early Detection Seminar Series – Azra Raza, M.D.
Mar 19 @ 11:00 am – 12:30 pm CANCELLED
CANCELLED - Cancer Early Detection Seminar Series - Azra Raza, M.D. @ CANCELLED

Please note this seminar is now cancelled and will be rescheduled for a future date. Please contact Ashley Williams (ashleylw@stanford.edu) with any questions or concerns. Thank you for your understanding!

CEDSS: “The First Cell and the Human Cost of going after Cancer’s last”

Azra Raza, MD

Chan Soon-Shiong Professor of Medicine

Director, Myelodysplastic Syndrome Center

Columbia University Medical Center

May
26
Tue
2020
Cancer Early Detection Seminar Series - Eric Fung, M.D., Ph.D. @ Zoom - See Description for Zoom Link
Cancer Early Detection Seminar Series – Eric Fung, M.D., Ph.D.
May 26 @ 11:00 am – 12:00 pm Zoom - See Description for Zoom Link
Cancer Early Detection Seminar Series - Eric Fung, M.D., Ph.D. @ Zoom - See Description for Zoom Link

CEDSS: “Multicancer detection of early-stage cancers with simultaneous tissue localization using a plasma cfDNA-based targeted methylation assay”

Eric Fung, M.D., Ph.D.

Senior Medical Director

GRAIL, Inc.

Please see zoom details below:
Meeting URL: https://stanford.zoom.us/j/230531527
Dial: +1 650 724 9799 (US, Canada, Caribbean Toll) or +1 833 302 1536 (US, Canada, Caribbean Toll Free)
Meeting ID: 230 531 527

ABOUT

Dr. Eric Fung is Vice President, Clinical Development at GRAIL, where he leads several clinical development programs in support of the development of a blood-based multi-cancer detection test. Dr. Fung has previously held clinical development and R&D leadership roles at Affymetrix, Vermillion, Ciphergen, and Roche Molecular Diagnostics. Dr. Fung has led clinical trials leading to FDA clearance of multiple IVD products. Dr. Fung received his MD, PhD from the Johns Hopkins University School of Medicine.

 

Hosted by: Sanjiv Sam Gambhir, M.D., Ph.D.
Spon
sored by the Canary Center & the Department of Radiology 
Stanford University – School of Medicine